The ROS accumulation can also activate the AMPK (AMP-activated protein kinase) pathway to inhibit mTOR (mammalian target of rapamycin) and activate FOXO (forkhead box O) in tumor cells, promoting metabolic reprogramming to alleviate ROS accumulation [85]. This evidence concerns the gene MTOR and neoplasm.